Really helped a layman like me have a chance of understanding how GT tech works. Very exciting. I believe the FDA approves drug for market with ongoing safety tests. See you at 80-100 by May, 2015 .Unless acquired pre April.
I have to ask the question could Pfizer be interesting at acquiring CLDN. They already have some skin in the game and the manufacturing and channels to distribute. They would not have to wait for FDA news. They have 33bb on cash and have been on a hunt for a acquisition , albeit a much bigger one. Like Teva. Anyway, sorry about the post as it could seem like more dribble but the I believe the question has merit.
throw in the fact that the float is 12mm ,brokerage houses will allow for margin again once the V picks and that the FDA MOMO crowd will show up in the next 30 days we could be looking at 30 pre announcement. in my humble opinion.... yet, i'm often wrong just ask my wife.
that sucks.. when do think the brokerage houses will allow for margin again. ... seems like volume would have to really pick up as its all about liquity
thanks Banman.... I'm adding here as well. I hate to ask a tea leaf question as I don't want to annoy anyone. But, I was thinking based on similar story stocks that CLDN could run to 30- 40 pps prior to announcement then if approved could perhaps get to 75... call me crazy. any thoughts on this weegie board question... lol !
Thanks for framing the bull /bear case so clearly. On the bull side, I was also factoring in the FDA had granted them a Breakthrough Therapy designation based on risk reduction on phase 1. Furthermore, Ogut comments regarding the dosses being to inadequate for humans versus rate confuses me as the finding of phase 1 data was based on humans ? or was the phase 1 on rats and the phase 2 data to be released is on humans ? sorry to sound so ignorant. please advise ? thanks for the assistance.
thanks brother for the conviction. adding here as well. fingers crossed. Based on your experience with running into a FDA decision when do you think we start getting some upside MOMO ? thanks again man. nice to have someone to communicate with.
broad market sell off took down BIO across board. Sell side V was weak for must. profit takers nothing more. EU QE should restore market next week. Swiss news should be absorbed. I believe BIO is the best sector to be in for 2015. Stay the course. i¨m buying dips.
I believe the author of the below article really captured the story. Yet, he's a making a case for CLDN on the long side. Always do your own due diligence. Never allow someone to make your trading / investing decisions for you. You've worked hard for your capitol. Protect it.
Gentlemen, I pasted some collateral material for you to review as a reply to early post. scroll down. Ok, enough from me. BY the way, you can check out my company at trackingtheinsiders dotcom. let me know if you're interested in free lifetime memberships. rick